Nabumetone Shortage Update: What Patients Need to Know in 2026

If you or someone you care for relies on nabumetone to manage arthritis pain, you may have heard concerns about availability. Here is the latest information on nabumetone's supply status in 2026, why patients sometimes struggle to fill prescriptions, and what to do if your pharmacy is out of stock.

Is Nabumetone in Shortage in 2026?

No — nabumetone is not on the FDA's official drug shortage list as of 2026. Generic nabumetone in 500 mg, 750 mg, and 1,000 mg tablets is available from multiple manufacturers. The FDA publishes its current shortage list at the ASHP Drug Shortages Resource Center, and nabumetone does not appear on it.

However, absence from the national shortage list doesn't mean your local pharmacy always has it on the shelf. Individual pharmacies make stocking decisions based on their patient population, purchasing contracts, and demand. For a moderately prescribed generic like nabumetone, some locations simply carry less stock — and when demand briefly spikes, they may run low.

What Happened to Brand Name Relafen?

The original Relafen brand was discontinued by its manufacturer. Relafen DS (the 1,000 mg double-strength tablet) is still available. Patients who relied on the original Relafen brand should be able to use generic nabumetone as a direct equivalent — but if your pharmacy's usual supplier has changed, availability can feel spotty during transitions.

Why Do Some Pharmacies Run Out of Nabumetone?

Even without a declared national shortage, several factors can leave patients unable to fill their nabumetone prescription at a particular pharmacy:

Moderate prescription volume: Nabumetone generates approximately 800,000 U.S. prescriptions per year — relatively modest for a generic, which means pharmacies may order smaller quantities less frequently.

Strength-specific stocking: Many pharmacies stock only the 1,000 mg strength. The 500 mg and 750 mg tablets may require a special order.

Manufacturer switches: With multiple generic manufacturers, a pharmacy's wholesaler may switch suppliers, causing a temporary gap while new stock is ordered.

Geographic variation: In rural areas or smaller communities with fewer pharmacies, any given location may carry a more limited inventory of less common generics.

How Do Drug Shortages Typically Affect NSAID Access?

NSAIDs as a drug class are generally not subject to the same severe shortages that affect injectable medications or complex biologic drugs. Most oral generic NSAIDs — including nabumetone, meloxicam, and naproxen — remain available even when supply chain disruptions affect other drug categories. Still, because the U.S. generic drug supply depends on a complex web of overseas manufacturers and domestic distributors, even stable medications can experience temporary localized shortfalls.

What Patients Should Do Right Now

Check availability with medfinder: medfinder calls pharmacies near you to check stock, so you don't have to spend time on hold.

Don't wait until you're out: Start looking for refills when you have about a week of medication left, not the day you run out.

Ask your pharmacy to special-order: If your pharmacy is temporarily out, they can usually get nabumetone within 1–2 business days.

Consider mail-order: A 90-day mail-order supply ensures you won't face a refill gap due to local stock issues.

Talk to your doctor about alternatives: If nabumetone remains unavailable, meloxicam, celecoxib, or naproxen may be appropriate substitutes.

The Bottom Line for 2026

Nabumetone is not in a declared national shortage in 2026, but localized pharmacy availability gaps exist. Being proactive — checking stock early, using tools like medfinder, and maintaining a supply buffer — gives you the best chance of staying on your medication without interruption. Read our full guide on how to find nabumetone in stock for step-by-step strategies.